3N

Alphamab OncologyFRA Alphamab Stock Report

Last reporting period 30 Jun, 2023

Updated 13 Nov, 2024

Last price

Market cap $B

0.346

Micro

Exchange

XFRA - Deutsche Boerse AG

View Section: Price ratios

Alphamab Statements

3N

Data from Alphamab`s earning releases including common size income statement and balance sheet.

Common size analysis evaluates financial statements by expressing each line item as a percentage of a base amount for that period.

Key Information:

Report currency:

CNY - Chinese yuan

Last reporting period:

30 Jun, 2023

Next reporting period:

27 Dec, 2023

Report frequency:

Semi-annual

Earnings release date:

Expected release date:

Alphamab Income Statement


Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

B

M

CNY (except Earnings per share)

Financial

Revenue


Cost of sales


Gross profit


Research and development


Selling, general and administrative


Total operating expenses


Operating income


Interest expense


Other income


Income before tax


Provision for income taxes


Net income


Diluted earnings per share


Shares outstanding after dilution


2023-06-30
%

136.47

20.5 %

100

33.165

24.3

103.3

23.1 %

75.7

194.68

142.7

33.244

24.4

222.77

-19.3 %

163.2

-119.47

37.8 %

-87.5

80.154

58.7

-0.545

-0.4

-39.862

77.7 %

-29.2

0

-39.862

77.7 %

-29.2

-0.042

957.14

2022-12-31
%

113.28

111.5 %

100

29.387

25.9

83.889

116.5 %

74.1

251.84

222.3

42.674

37.7

275.95

8.3 %

243.6

-192.06

11.1 %

-169.5

14.2

12.5

-0.556

-0.5

-178.41

-21.1 %

-157.5

0

-178.41

-21.1 %

-157.5

-0.19

936.92

2022-06-30
%

53.569

-63.3 %

100

14.82

27.7

38.749

-72.9 %

72.3

216.4

404

44.097

82.3

254.7

-8.5 %

475.5

-215.95

-59.4 %

-403.1

69.203

129.2

-0.566

-1.06

-147.31

-1.6 %

-275

0

-147.31

-1.6 %

-275

-0.157

936.09

2021-12-31
%

146.02

100

3.028

2.1

142.99

97.9

249.41

170.8

39.12

26.8

278.5

6.7 %

190.7

-135.5

48.1 %

-92.8

-9.175

-6.3

-0.373

-0.3

-145.05

45.7 %

-99.3

0

-145.05

45.7 %

-99.3

-0.155

935.85

2021-06-30
%

100

0

0

231.95

0

38.131

0

261.12

31.1 %

0

-261.12

-31.1 %

0

-6.242

0

0

-267.36

17.6 %

0

0

-267.36

17.6 %

0

-0.286

935.12

2020-12-31
%

100

0

0

197.52

0

37.629

0

199.11

19.9 %

0

-199.11

-19.9 %

0

-125.56

0

0

-324.67

-214.9 %

0

0

-324.67

-214.9 %

0

-0.348

933.92

2020-06-30
%

100

0

0

133.72

0

40.579

0

166.12

-78.3 %

0

-166.12

78.3 %

0

63.023

0

0

-103.1

86.7 %

0

0

-103.1

86.7 %

0

-0.111

925.58

2019-12-31
%

100

0

0

110.9

0

93.075

0

766.4

1282.9 %

0

-766.4

-1282.9 %

0

16.128

0

0

-773.96

-1216.6 %

0

0

-773.96

-1216.6 %

0

-2.177

355.45

2019-06-30
%

100

0

0

55.752

0

24.661

0

55.419

-37 %

0

-55.419

37 %

0

9.512

0

0

-58.785

42.7 %

0

0

-58.785

39.9 %

0

-0.082

717.61

2018-12-31
%

100

0

0

39.031

0

16.617

0

87.976

-12 %

0

-87.976

12 %

0

-9.702

0

0

-102.59

-2.5 %

0

0

-97.892

-88.4 %

0

-0.136

717.61

2018-06-30
%

100

0

0

26.577

0

9.24

0

99.924

0

-99.924

0

-0.118

0

0

-100.04

0

0

-51.951

0

-0.072

717.61

View Section: Balance Sheet